Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma

SIMPLE SUMMARY: Despite the advances in treatment of patients diagnosed with advanced melanoma, long-term benefits remain limited due to primary and acquired resistance. Reliable biomarkers may support treatment decisions and should optimize treatment efficacy. By using a homogeneous population of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wendlinger, Simone, Wohlfarth, Jonas, Kreft, Sophia, Siedel, Claudia, Kilian, Teresa, Dischinger, Ulrich, Heppt, Markus V., Wistuba-Hamprecht, Kilian, Meier, Friedegund, Goebeler, Matthias, Schadendorf, Dirk, Gesierich, Anja, Kosnopfel, Corinna, Schilling, Bastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104271/
https://www.ncbi.nlm.nih.gov/pubmed/35565423
http://dx.doi.org/10.3390/cancers14092294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104271/
https://www.ncbi.nlm.nih.gov/pubmed/35565423
http://dx.doi.org/10.3390/cancers14092294

Ejemplares similares